111 related articles for article (PubMed ID: 8371201)
1. In vivo analysis of murine serum sulfate metabolism and splenic glycosaminoglycan biosynthesis during acute inflammation and amyloidosis.
Lyon AW; Anastassiades T; Kisilevsky R
J Rheumatol; 1993 Jul; 20(7):1108-13. PubMed ID: 8371201
[TBL] [Abstract][Full Text] [Related]
2. Characterization of tissue and plasma glycosaminoglycans during experimental AA amyloidosis and acute inflammation. Qualitative and quantitative analysis.
Snow AD; Kisilevsky R; Stephens C; Anastassiades T
Lab Invest; 1987 Jun; 56(6):665-75. PubMed ID: 3599910
[TBL] [Abstract][Full Text] [Related]
3. Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis.
Ailles L; Kisilevsky R; Young ID
Lab Invest; 1993 Oct; 69(4):443-8. PubMed ID: 8231112
[TBL] [Abstract][Full Text] [Related]
4. Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice.
Sugumaran G; Elliott-Bryant R; Phung N; Vitseva O; Kuberan B; Lech M
Scand J Immunol; 2004 Dec; 60(6):574-83. PubMed ID: 15584968
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of glycosaminoglycan deposition in splenic AA amyloidosis induced in mink.
Wien TN; Sørby R; Omtvedt LA; Landsverk T; Husby G
Scand J Immunol; 2004 Dec; 60(6):600-8. PubMed ID: 15584971
[TBL] [Abstract][Full Text] [Related]
6. Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis. A histochemical study.
Snow AD; Kisilevsky R
Lab Invest; 1985 Jul; 53(1):37-44. PubMed ID: 2409350
[TBL] [Abstract][Full Text] [Related]
7. Presence and role of glycosaminoglycans in amyloidosis.
Linker A; Carney HC
Lab Invest; 1987 Sep; 57(3):297-305. PubMed ID: 3626519
[TBL] [Abstract][Full Text] [Related]
8. Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor.
Sørby R; Espenes A; Landsverk T; Westermark G
Amyloid; 2008 Mar; 15(1):20-8. PubMed ID: 18266118
[TBL] [Abstract][Full Text] [Related]
9. Co-deposition of basement membrane components during the induction of murine splenic AA amyloid.
Lyon AW; Narindrasorasak S; Young ID; Anastassiades T; Couchman JR; McCarthy KJ; Kisilevsky R
Lab Invest; 1991 Jun; 64(6):785-90. PubMed ID: 2046330
[TBL] [Abstract][Full Text] [Related]
10. In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis.
Li JP; Galvis ML; Gong F; Zhang X; Zcharia E; Metzger S; Vlodavsky I; Kisilevsky R; Lindahl U
Proc Natl Acad Sci U S A; 2005 May; 102(18):6473-7. PubMed ID: 15843464
[TBL] [Abstract][Full Text] [Related]
11. FK506 inhibits murine AA amyloidosis: possible involvement of T cells in amyloidogenesis.
Ueda M; Ando Y; Nakamura M; Yamashita T; Himeno S; Kim J; Sun X; Saito S; Tateishi T; Bergström J; Uchino M
J Rheumatol; 2006 Nov; 33(11):2260-70. PubMed ID: 16981291
[TBL] [Abstract][Full Text] [Related]
12. Extremely active murine amyloid enhancing factor.
Shtrasburg S; Livneh A; Gal R; Pras M
Clin Exp Rheumatol; 1996; 14(1):37-42. PubMed ID: 8697655
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E1 inhibition of experimental amyloidosis in CBA/J mice.
Brandwein SR; Sipe JD; Skinner M; Cohen AS
J Rheumatol; 1985 Jun; 12(3):418-26. PubMed ID: 4045840
[TBL] [Abstract][Full Text] [Related]
14. Induction of amyloid enhancing factor and its biological properties in murine alveolar hydatidosis.
Abankwa GV; Ali-Khan Z
Br J Exp Pathol; 1988 Feb; 69(1):123-32. PubMed ID: 3348956
[TBL] [Abstract][Full Text] [Related]
15. Are elevated serum amyloid A levels and amyloid-enhancing factor sufficient to induce inflammation-associated amyloid deposition?
Kisilevsky R; Tan R; Subrahmanyan L; Snow A
Appl Pathol; 1984; 2(6):308-15. PubMed ID: 6400464
[TBL] [Abstract][Full Text] [Related]
16. Further characterization of amyloid-enhancing factor.
Axelrad MA; Kisilevsky R; Willmer J; Chen SJ; Skinner M
Lab Invest; 1982 Aug; 47(2):139-46. PubMed ID: 7109539
[TBL] [Abstract][Full Text] [Related]
17. Heparan sulfate as a therapeutic target in amyloidogenesis: prospects and possible complications.
Kisilevsky R; Ancsin JB; Szarek WA; Petanceska S
Amyloid; 2007 Mar; 14(1):21-32. PubMed ID: 17453622
[TBL] [Abstract][Full Text] [Related]
18. Amyloid enhancing factor-loaded macrophages in amyloid fibril formation.
Shirahama T; Miura K; Ju ST; Kisilevsky R; Gruys E; Cohen AS
Lab Invest; 1990 Jan; 62(1):61-8. PubMed ID: 2296158
[TBL] [Abstract][Full Text] [Related]
19. Brefeldin A inhibits experimentally induced AA amyloidosis.
Stenstad T; Husby G
J Rheumatol; 1996 Jan; 23(1):93-100. PubMed ID: 8838515
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin: its potential significance in murine AA amyloidogenesis.
Chronopoulos S; Lembo P; Alizadeh-Khiavi K; Ali-Khan Z
J Pathol; 1992 Jun; 167(2):249-59. PubMed ID: 1321903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
